Vera good reception

Verastem Inc. (NASDAQ:VSTM) raised $55 million through the sale of 5.5 million shares at $10 in a bumped-up IPO, becoming the first U.S. biotech to price an IPO this year. The deal values the preclinical cancer play at a lofty $202.3 million